Skip to content

Clinical trials

Phase 2 Mental Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 2 Country / region: United States Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20062
20073
20082
20091
20101
20113
20122
20133
20144
20151
20161
20173
20184
20194
20204
20214
202210
20233
20244
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting9
Terminated5
Withdrawn3
Not yet recruiting2
Active, not recruiting2
Suspended1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital4
MapLight Therapeutics4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AbbVie3
Alkahest, Inc.3
Novartis Pharmaceuticals3
University of California, San Diego3
Corcept Therapeutics2
GlaxoSmithKline2
Marinus Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders76
Schizophrenia22
Nervous System Diseases16
Mood Disorders15
Brain Diseases14
Central Nervous System Diseases13
Major Depressive Disorder13
Psychotic Disorders13
Dementia11
Alzheimer Disease8

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.